References
Dorbala S, Cuddy S, Falk RH. How to image cardiac amyloidosis: A practical approach. JACC Cardiovasc Imaging 2019. https://doi.org/10.1016/j.jcmg.2019.07.015.
Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS. Transthyretin amyloid cardiomyopathy: JACC State-of-the-Art review. J Am Coll Cardiol 2019;73:2872-91.
Grogan M, Scott CG, Kyle RA, Zeldenrust SR, Gertz MA, Lin G, et al. Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system. J Am Coll Cardiol 2016;68:1014-20.
Witteles RM, Bokhari S, Damy T, Elliott PM, Falk RH, Fine NM, et al. Screening for transthyretin amyloid cardiomyopathy in everyday practice. JACC Heart Fail 2019;7:709-16.
Disclosures
Talal Asif, Tiago Araujo, Vasvi Singh have declare that they have no conflict of interest. Saurabh Malhotra—Pfizer Inc.: Speakers Bureau and Akcea Therapeutics: Advisory Board.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Funding
Becker Fund for Heart Research, Community Foundation of Greater Buffalo.
Rights and permissions
About this article
Cite this article
Asif, T., Araujo, T., Singh, V. et al. High prevalence of heart failure with reduced ejection fraction in patients with transthyretin cardiac amyloidosis. J. Nucl. Cardiol. 27, 1044–1046 (2020). https://doi.org/10.1007/s12350-020-02098-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12350-020-02098-0